Theragnostics, an Issue of Pet Clinics
Theragnostics, an Issue of Pet Clinics
Buch
- Herausgeber: Andrei Iagaru, Heather A Jacene
![Theragnostics, an Issue of Pet Clinics, Buch](https://media1.jpc.de/image/w468/front/0/9780443129216.jpg)
Derzeit nicht erhältlich.
Lassen Sie sich über unseren eCourier benachrichtigen, falls das Produkt bestellt werden kann.
Lassen Sie sich über unseren eCourier benachrichtigen, falls das Produkt bestellt werden kann.
- Elsevier Health Sciences, 06/2024
- Einband: Fester Einband
- ISBN-13: 9780443129216
- Erscheinungstermin: 6.6.2024
Ähnliche Artikel
![Siddhartha Mukherjee: The Song of the Cell, Buch](https://media1.jpc.de/image/h90/front/0/9781982117351.jpg)
Siddhartha Mukherjee
The Song of the Cell
Buch
EUR 31,90*
![John A Kellum: Continuous Renal Replacement Therapy, Buch](https://media1.jpc.de/image/h90/front/0/9780190225537.jpg)
John A Kellum,
Continuous Renal Replacement Therapy
Buch
EUR 87,14*
![National Research Council: Diet, Nutrition, and Cancer, Buch](https://media1.jpc.de/image/h90/front/0/9780309078535.jpg)
National Research Council, Division On Earth And Life Studies, Commission On Life Sciences, Committee on Diet Nutrition and Cancer
Diet, Nutrition, and Cancer
Buch
EUR 51,78*
Klappentext
Contains 12 relevant, practice-oriented topics including theragnostics trials; neuroendocrine tumors: diagnostics; prostate-specific membrane antigen: diagnostics; theragnostics: post-therapy imaging; fibroblast-activation-protein inhibitors (FAPI) theragnostics; and more.Provides in-depth clinical reviews on theragnostics, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
In this issue of PET Clinics, guest editors Drs. Andrei Iagaru and Heather A. Jacene bring their considerable expertise to the topic of Theragnostics. Top experts in the field discuss neuroendocrine tumors: beta-labeled peptides; prostate-specific membrane antigen: interpretation criteria, standardized reporting and the use of artificial intelligence; prostate cancer (gastrin-releasing peptide receptor); selective internal radiation therapy; future directions in theragnostics; and more.